Travere Therapeutics, Inc.: Form 8-K, filed May 1, 2025
Filed with the SEC on May 1, 2025 and accepted by EDGAR at May 1, 2025, 20:05 ET.
Items reported
- Item 2.01 Completion of an acquisition or disposition
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001438533-25-000025. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.